PathogenDx's innovative technology can support U.S. It's also costly from an equipment and consumables standpoint, and unable to identify between variants, whereas PathogenDx's Detect x-Cv is 1/15th the cost of a sequencer and 50-90% less expensive than sequence testing of samples. On the other hand, next generation sequencing takes two to three weeks for results, by which time the COVID-19 variants could have changed, and requires high-end bioinformatics labor.

The multiplex array technology can fit 150 different probes to avoid the chance of false negatives by testing for multiple viruses and its mutations, and provides results within just four hours. PathogenDx's Detect x-Cv assay tests for all variants in a single sample to discern if a positive sample from an EUA authorized platform is from a specific variant. Meanwhile, we've reached a crucial milestone with domestic and international validation of our Detect x-Cv assay, which brings us one step closer to expanded distribution internationally.'

Patel added: 'We're proud to partner with Axiology Labs, whose large distribution network will help increase testing of COVID-19 variants across Africa and Thailand, where we are seeing some of the highest death rates. Customers include numerous government entities, research institutions and universities as well as private sector biotech and analytical corporations. The business offers turn-key solutions across the life science spectrum ranging from sales and distribution of specialised pharmaceutical equipment to the implementation and training of laboratory technicians and ongoing supply chain management. This partnership is critical to supporting the fight against COVID-19 and its variants in Africa and Thailand in an affordable and timely manner.'ДЄxiology Labs operates in the Life Science Sector with an established footprint across twelve countries on the African continent and growing. 'Low-income countries are seeing the highest cases of COVID-19 and are in dire need of access to testing to help mitigate the spread. 'We're thrilled to partner with PathogenDx to distribute their Detect x-Cv assay with the ultimate goal of commercializing the technology to make it available to our own internal lab network,' said Gideon Burger, CEO of Axiology Labs. Real-time monitoring of community spread through COVID-19 variant tests is necessary to mitigate community infection rates and the development of new variants. At the time of this release, approximately 42.7% of Americans are not vaccinated, providing an avenue for new variants to arise, spread and further mutate through the unvaccinated population. There are currently four SARS-CoV-2 variants categorized by The World Health Organization (WHO) and the Centers for Disease Control (CDC) as Variants of Concern (VoC), including the infamous Delta B.1.617.2 variant and two Variants of Interest (VoI).

Detectx review